Chargement en cours...
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
Metastatic melanoma is near-to-invariably a fatal disease. As novel therapeutic strategies against metastatic melanoma are urgently needed, we have tested a combinatorial regimen consisting of conventional chemotherapy coupled to bevacizumab, a monoclonal antibody that inhibit angiogenesis, demonstr...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3667915/ https://ncbi.nlm.nih.gov/pubmed/23762809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24436 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|